(RTTNews) - Pulse Biosciences Inc. (PLSE), in an update to its recent FDA 510(k) submission to add the specific indication for treatment of sebaceous hyperplasia to expand the CellFX System's current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback